#therapies

Collection of therapies news, found 47 news.

Merck launches Vivera in Latin America

- Merck, a leading science and technology company, today announced the launch of its new consumer brand ...

LEO Pharma and 4SC Discovery Announce Exclusive Research and License Agreement

-     LEO Pharma A/S, a global pharmaceutical company specialising in dermatology, has entered into ...

Art Levinson, Sergey Brin and Anne Wojcicki, Mark Zuckerberg and Priscilla Chan

-11 Inaugural winners receive US$3 million each for Groundbreaking Achievements in Life Science ...

Stretta® Therapy for GERD Receives Strongest Recommendation in SAGES New Clinical Guideline

Grade Recommendation: Strong (Highest)      GREENWICH, Connecticut, Feb. 11, 2013 ...

Olympus Biotech International Ltd and BonAlive Biomaterials Ltd Announce Distribution Agreement

-     BonAlive Biomaterials Ltd, a manufacturer of implantable medical devices and an emerging ...

Berg Pharma Presents Key Findings In Cancer Systems Biology And Mitochondrial Metabolism

-     Berg Pharma, a Boston based pharmaceutical company presented novel data today pertaining to ...

Ingenuity Systems and Life Technologies Introduce Complete End-to-End Solution

-     Ingenuity(R) iReport(TM) for Real-Time PCR, optimized for TaqMan(R)Gene Expression Assays ...

Investigational Oral Multiple Sclerosis Therapy Teriflunomide (*) Aubagio (R)) Significantly Reduced

-            - Findings from Two-Year Pivotal Phase III TEMSO Trial ...

More Patients with Type 2 Diabetes Reach HbA[1c] Target with Apidra(R) on top of Lantus(R)

-            - First Randomized Controlled Trial to Show That Basal Plus ...

UGM to hold seminar on nutraseutical products

Gadjah Mada University (UGM) will hold a national seminar on the benefits, safety and development prospects of ...

Sanofi's Investigational Semuloparin in Cancer Patients Initiating Chemotherapy Shows a 64 % Risk Re

-        - Results of Phase III SAVE-ONCO Study Selected for "Best of ASCO 2011" ...

Novel First-in-Class Anti-Cancer Agent in Development by Niiki Pharma Shows Promising Phase I Result

- Phase I Data for NKP-1339, a First-in-Class Transferrin Targeted Anti-Cancer Agent to be Presented at Upcoming ...

Procoralan(R) Significantly Improves Quality of Life as Well as Survival

-        Results of a new analysis from the largest-ever morbi-mortality study of ...

RI calls on int`l community to cut narcotics demand

Indonesia has called on the international community to cut global demand for narcotics and drugs as part of a ...

Accumetrics Announces Publication of GRAVITAS Primary Results in JAMA

-Evaluation of Alternative Treatment Strategies Incorporating Platelet Function Testing Recommended    ...